The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited .

Filed returns
11
match these filters
Matching filed returns per period 0 1 2 3 5 Sep–Dec 2015: 1 filed returns May–Aug 2017: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 4 filed returns May–Aug 2026: 2 filed returns 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Novartis Ireland Limited Health National Cardiovascular Health Strategy (Public policy or programme) 5 On lobbying.ie
May–Aug 2026 Novartis Ireland Limited Health Valuing Innovation & Advanced Cancer Therapy - policy and access (Public policy or programme) 27 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Attended an event for World Cancer Day (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Supporting a Health Policy Partnership Initiative for them to run a roundtable and draft a white paper with policy stakeholders. (Public policy or programme) 26 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Roundtable policy meeting to discuss EU and Irish Cardiovascular Strategy (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2026 Novartis Ireland Limited Health Implementation of the decision to include SMA in newborn screening (Matters involving public funds) 10 On lobbying.ie
Sep–Dec 2025 Novartis Ireland Limited Health Invitation to a meeting to discuss EU and Irish Cardiovascular Strategy (Public policy or programme) 14 On lobbying.ie
Sep–Dec 2024 Novartis Ireland Limited Health Implementation of SMA testing into the heel prick test for newborns (Matters involving public funds) 7 On lobbying.ie
May–Aug 2024 Novartis Ireland Limited Health Newborn screening for spinal muscular atrophy (SMA) is implemented for babies in Ireland (Matters involving public funds) 25 On lobbying.ie
May–Aug 2017 Novartis Ireland Limited Health Highlight delay in reimbursing Entresto (Heart Failure medine), the first new innovation in heart failure in a decade considered cost effective in July 2016 (Matters involving public funds) 23 On lobbying.ie
Sep–Dec 2015 Novartis Ireland Limited Health Making heart failure a national priority (Public policy or programme) 19 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 11 100.0%